Opko Health, Inc. SEC filings OPK
Opko Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 14, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 6, 2026 | — |
| 4 | Insider transaction | Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Other events
|
Oct 2, 2026 | Sep 30, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Jun 30, 2026 |
| 10-Q/A | Amended quarterly report | Aug 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 14, 2026 | Aug 13, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 7, 2026 | — |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 10-Q | Quarterly report | Jul 27, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2026 | Jul 27, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | May 15, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | Apr 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 20, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2026 | Mar 18, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 18, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 31, 2025 |
| 10-Q | Quarterly report | Oct 29, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2025 | Jul 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 9, 2025 | — |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 8-K |
Current report
Officer or director change
|
May 29, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 10, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 3, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 3, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 2, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 1, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 28, 2025 | Mar 27, 2025 |
| 10-K/A | Amended annual report | Mar 21, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 17, 2025 |
| ARS | Annual report to shareholders | Mar 14, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 14, 2025 | — |
| DEF 14A | Proxy statement | Mar 14, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 11, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Mar 3, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 11, 2024 |
| 4 | Insider transaction | Nov 29, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 22, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 20, 2024 | — |
| 4/A | Filing | Nov 20, 2024 | Nov 8, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 15, 2024 | — |
| 4 | Insider transaction | Nov 14, 2024 | Nov 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Nov 8, 2024 | Nov 8, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 4 | Insider transaction | Sep 27, 2024 | Sep 27, 2024 |
| 4/A | Filing | Sep 27, 2024 | Sep 25, 2024 |
| 4 | Insider transaction | Sep 26, 2024 | Sep 25, 2024 |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 18, 2024 | — |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
|
Sep 16, 2024 | Sep 16, 2024 |
| DEFR14A | Form defr14a | Aug 30, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 29, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 23, 2024 | — |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 12, 2024 | — |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 26, 2024 | — |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jul 17, 2024 | Jul 17, 2024 |
| 4 | Insider transaction | Jul 9, 2024 | Jul 5, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 5, 2024 | — |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 144/A | Filing | Jun 28, 2024 | — |
| 144 | Notice of proposed sale | Jun 28, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 17, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 29, 2024 | Mar 28, 2024 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2024 | Mar 27, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 12, 2024 |
| ARS | Annual report to shareholders | Mar 7, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 1, 2024 | Dec 31, 2023 |
| NT 10-K | Form nt 10-k | Mar 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Feb 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 21, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 16, 2024 | Mar 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2024 | Feb 9, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 7, 2024 |
| 4 | Insider transaction | Jan 29, 2024 | Jan 29, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 24, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 24, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 24, 2024 | Jan 22, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 22, 2024 | — |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 17, 2024 | Jan 17, 2024 |
| 4 | Insider transaction | Jan 16, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 11, 2024 |
| 4 | Insider transaction | Jan 10, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Jan 9, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 5, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Nov 14, 2023 | Nov 13, 2023 |
| 4 | Insider transaction | Nov 13, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Nov 13, 2023 | Nov 10, 2023 |
| 4 | Insider transaction | Nov 13, 2023 | Nov 10, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 31, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2023 | Sep 28, 2023 |
| 4 | Insider transaction | Aug 18, 2023 | Aug 17, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 9, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 7, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2023 | Jun 29, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OPK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 944809
- Former names
- EXEGENICS INC (until Jun 13, 2007); eXegenics Inc (until Jun 13, 2007); CYTOCLONAL PHARMACEUTICS INC /DE (until Jun 4, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.